Summary
Placental transport and tissue uptake of amino acids were studied in streptozotocin(STZ)-induced
diabetic rats by using the non-metabolizable amino acid [U-14C]-α-amino-isobutyric
acid (AIB). Fifteen minutes prior to autopsy, animals of each group, control (C),
diabetic (D), diabetic-insulin treated (Dl) and diabetic-T4 followed by 3-5-Dimethyl-3′-isopropyl-L-thyronine (DIMIT) treated (DTD), received
an injection of the [U-14C]-AIB SC. Disintegrations per minute (DPM) were measured
in serum and tissues subsequent to autopsy. There were no differences in maternal
serum DPM/ml among groups. Fetal serum DPM, however, were lower in D and DTD groups
than in the C group. The whole fetal tissue homogenate radioactivity was lower in
the D, DTD, and DI groups than in the C group. In general, more AIB was taken up by
fetal tissues of C than D animals. Maternal liver AIB uptake was reduced in D, DI,
and DTD from C animals and net placental transport of AIB was less in D and DTD than
C animals. Fetal liver protein concentrations were depressed in D and DTD animals
from C and Dl, but fetal brain protein concentrations showed no significant differences.
Furthermore, the lower organ and fetal body weights of the D and DTD groups compared
with the C and Dl groups support the proposal that fetal anabolism is impaired. Maternal
and fetal serum T4 concentrations were lower in D and DTD than in C and DI animals. Insulin therapy
improved serum T4 levels in both mother and fetuses. It did not, however, correct all other measured
parameters. The thyroxine-DIMIT treatment significantly corrected few parameters.
The data support the theory that alterations in fetal amino acid levels may result
from changes in placental transfer of amino acids from the maternal to the fetal compartment.
They further suggest that uptake of amino acids by specific maternal and fetal tissues
is compromised.
Key-Words
Streptozotocin
-
3,5-Dimethyl-3′-Isopropyl-L-Thyronine (DIMIT)
-
Insulin
-
α-Amino-Isobutyric(AIB)
-
Transport
-
Amino Acid Metabolism